Ortoma AB (publ) (STO:ORT.B)

Theseus Pharmaceuticals Income Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	90.09	60.59	62.01	23.37	20	18.43
Revenue	90.09	60.59	62.01	23.37	20	18.43
Revenue Growth (YoY)	45.39%	-2.29%	165.31%	16.87%	8.54%	55.42%
Cost of Revenue	45.83	40.29	41.81	34.31	28.45	25.31
Gross Profit	44.26	20.3	20.2	-10.94	-8.45	-6.88
Selling, General & Admin	24.4	21.79	12.36	6.38	6.11	2.08
Other Operating Expenses	1.97	-0.87	23.67	-2.43	-1.29	-0.2
Operating Expenses	38.94	33.14	42.18	4.05	4.9	1.92
Operating Income	5.32	-12.84	-21.98	-14.99	-13.35	-8.8
Interest Expense	-0.01	-0	-0.56	-0.78	-0	-0
Interest & Investment Income	0.83	1.21	0.67	0.01	-	-
Other Non Operating Income (Expenses)	-	-	-	-	2.56	-
EBT Excluding Unusual Items	6.14	-11.63	-21.87	-15.75	-10.79	-8.8
Pretax Income	6.11	-11.63	-21.87	-15.75	-10.79	-8.8
Net Income	6.11	-11.63	-21.87	-15.75	-10.79	-8.8
Net Income to Common	6.11	-11.63	-21.87	-15.75	-10.79	-8.8
Shares Outstanding (Basic)	37	37	29	20	19	18
Shares Outstanding (Diluted)	37	37	29	20	19	18
Shares Change (YoY)	2.04%	26.01%	48.48%	1.93%	8.27%	14.45%
EPS (Basic)	0.16	-0.31	-0.74	-0.79	-0.55	-0.49
EPS (Diluted)	0.16	-0.31	-0.74	-0.79	-0.55	-0.49
Free Cash Flow	33.79	-22.14	13.35	-8.35	-15.25	-8.39
Free Cash Flow Per Share	0.91	-0.60	0.45	-0.42	-0.78	-0.47
Gross Margin	49.13%	33.51%	32.58%	-46.79%	-42.24%	-37.34%
Operating Margin	5.90%	-21.19%	-35.45%	-64.13%	-66.75%	-47.75%
Profit Margin	6.78%	-19.19%	-35.27%	-67.39%	-53.95%	-47.76%
Free Cash Flow Margin	37.51%	-36.54%	21.54%	-35.73%	-76.26%	-45.55%
EBITDA	5.93	-12.58	-21.84	-14.88	-13.27	-8.76
EBITDA Margin	6.58%	-20.76%	-35.23%	-63.67%	-66.34%	-47.53%
D&A For EBITDA	0.61	0.26	0.14	0.11	0.08	0.04
EBIT	5.32	-12.84	-21.98	-14.99	-13.35	-8.8
EBIT Margin	5.90%	-21.19%	-35.45%	-64.13%	-66.75%	-47.75%
Revenue as Reported	90.45	62.33	64.51	25.81	21.29	18.62

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.